PFBT
CLLS

Parkside Financial Bank & Trust’s Cellectis CLLS Stock Holding History

Parkside Financial Bank & Trust’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-147
Closed -$309 – 2034
2022
Q4 		$309 Hold
147
– – ﹤0.01% 1943
2022
Q3 		$0 Hold
147
– – ﹤0.01% 1812
2022
Q2 		$0 Hold
147
– – ﹤0.01% 1829
2022
Q1 		$1K Hold
147
– – ﹤0.01% 1704
2021
Q4 		$1K Hold
147
– – ﹤0.01% 1702
2021
Q3 		$2K Hold
147
– – ﹤0.01% 1526
2021
Q2 		$2K Hold
147
– – ﹤0.01% 1513
2021
Q1 		$3K Buy
+147
New +$3.63K ﹤0.01% 1360

Other funds holding CLLS

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Parkside Financial Bank & Trust's CLLS Position: Q1 2023 in Review

Parkside Financial Bank & Trust sold out of Cellectis (CLLS) in Q1 2023, closing a stake of 147 shares — an estimated $309 sold.

Parkside Financial Bank & Trust first reported a position in CLLS in Q1 2021 and held it in 8 quarters. The position peaked at $3K in Q1 2021. 34 funds tracked by Wall St. Rank hold CLLS as of Q1 2023.

  • Parkside Financial Bank & Trust reported no remaining Cellectis position as of Q1 2023 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 147 Cellectis shares in Q1 2023, an estimated $309.
  • Parkside Financial Bank & Trust first reported a position in Cellectis in Q1 2021 and held it in 8 quarters.
  • Parkside Financial Bank & Trust's Cellectis position peaked at $3K in Q1 2021.
  • 34 funds tracked by Wall St. Rank held Cellectis as of Q1 2023.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2023, filed 4 May 2023.